Anika Therapeutics Inc
NASDAQ:ANIK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
US |
|
Adventus Holdings Ltd
SGX:5EF
|
SG |
|
KDA Group Inc
XTSX:KDA
|
CA |
|
Intercontinental Exchange Inc
NYSE:ICE
|
US |
|
F
|
flatexDEGIRO AG
OTC:FNNTF
|
DE |
|
A
|
Anheuser-Busch Inbev SA
JSE:ANH
|
BE |
|
I
|
Immutep Ltd
OTC:PRRUF
|
AU |
|
GN Store Nord A/S
F:GNN0
|
DK |
|
S
|
Shifa International Hospitals Ltd
KAR:SHFA
|
PK |
|
Harford Bank
OTC:HFBK
|
US |
|
B
|
Baltic Sea Properties AS
OSE:BALT
|
NO |
|
Minco Silver Corp
OTC:MISVF
|
CA |
|
Q
|
Quilter PLC
OTC:QUILF
|
UK |
|
Centaurus Energy Inc
XTSX:CTA
|
CA |
|
V
|
Volcano Bhd
KLSE:VOLCANO
|
MY |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
US |
|
Sage Group PLC
LSE:SGE
|
UK |
|
Chiyoda Corp
OTC:CHYCF
|
JP |
|
Z
|
Zoetis Inc
XMUN:ZOE
|
US |
|
Budimex SA
OTC:BDMXF
|
PL |
|
H
|
HUTCHMED (China) Ltd
NASDAQ:HCM
|
HK |
Bankruptcy Probability
Anika Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Anika Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
257.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Anika Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Anika Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.